Page 6 - Adxn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Will use proceeds from the transaction to pay its debts and make a shareholder distribution.

Addex Therapeutics (NASDAQ:ADXN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. […]

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a drop of 80.0% from the April 30th total of 500 shares. Based on an average trading volume of 4,300 shares, the short-interest ratio is […]

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 500 shares, an increase of 25.0% from the April 15th total of 400 shares. Based on an average daily volume of 3,100 shares, the […]

Zacks Investment Research downgraded shares of Addex Therapeutics (NASDAQ:ADXN – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Monday morning, Zacks.com reports. According to Zacks, “Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs […]